TENISHA MEKO: Open Payments
NPI 1356843528 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $68 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Astellas Pharma US Inc | 1 | $30 |
| ABBVIE INC. | 2 | $28 |
| Boston Scientific Corporation | 1 | $25 |
| Organon LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: Ozempic, FARXIGA, Veozah, VRAYLAR, General - Pain Management, NEXPLANON, SHINGRIX, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
